SEC Form 4 · accession 0001179110-16-021198
Tempest Therapeutics, Inc. · TPST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul W.D. Chapman
Officer — Chief Operating Officer
Period of report
Mar 3, 2016
Accepted (ET)
Mar 7, 2016 · 6:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001544227
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common StockF1 | $6.96 | Mar 3, 2016 | A | 350,000 | A | — | Mar 3, 2026 | Common Stock | 350,000 | 350,000 | D |
Explanation of responses
- F1The option vests as to 25% of the option shares on February 25, 2017 and vests as to an additional 6.25% of the shares at the end of each successive three-month period thereafter until February 25, 2020.